Paris† 30 June-2022 – In conjunction with the Wellcome Genome Campus in Cambridgeshire, UK, Atos today announces the official opening of its global Life Sciences Center of Excellence. The facility will provide on-campus scientists, and global genome and biodata institutes worldwide, early access to emerging technologies to support their research, help accelerate the process of bringing new drugs to market, and deliver tangible societal benefits.
The Atos Life Sciences Center of Excellence is an exploration, discovery and co-creation tool aimed at complementing existing Campus computing facilities with access to leading technologies, such as Quantum, High-Performance Computing, Edge Computing and AI supported through Atos’ products, services and expertise in these sectors. The facility will also feature leading technologies from Atos partners, including Arm, Intel and NetApp. First established during the Covid-19 incarceration crisis, this center provided support to researchers around the world studying many different aspects of the virus.
Atos experts around the world will work directly with scientists in genome and biological data research to turn ideas into reality, focusing specifically on enabling the implementation of precision health and accelerating the drug development using digital technologies. The goal is to create solutions that enable healthcare organizations to design efficient strategies to prevent and manage disease and to support pharmaceutical/biotech and medtech organizations in accelerating the development of targeted treatments/advanced medical devices and sensors, to tackle the biggest health problems. challenges in today’s society.
The results of the collaboration between Atos and health and life sciences stakeholders will be showcased at the Center of Excellence through innovation workshops, proof-of-concept production, demos and webinars.
dr. Natalia Jimenez, Global Life Sciences Product Leadatos said: “The opening of the Life Sciences Center of Excellence is an important milestone in Atos’ pioneering work to drive innovation in the healthcare and life sciences industries. By offering an ecosystem where genome and biological data research scientists can access to emerging technologies accompanied by means of leading Atos experts, the Center of Excellence will play a critical role in advancing discovery and innovation in life sciences, speeding up the time it takes to bring new drugs to market and deliver tangible benefits to patients.”
dr Julia Wilson, Associate DirectorWellcome Sanger Institute commentary: “We are happy that Atos has joined our Campus community, and look forward to working with them to maximize the vast array of opportunities the Center of Excellence will bring to scientists here and worldwide. Emerging technologies such as Quantum, High†Performance computer useSide Computing and AI keep transformatI have potential for progress personal data research, helping the life sciences sector to shorten the drug development process and reduce costs.”
Atos is a global leader in digital transformation with 111,000 employees and annual sales of c. €11 billion. Europe’s number one in cybersecurity, cloud and high-performance computing, the Group offers tailor-made end-to-end solutions for all sectors in 71 countries. As a pioneer in decarbonization services and products, Atos is committed to providing secure and low-carbon digital technology for its customers. Atos is an SE (Societas Europaea), listed on Euronext Paris and included in the CAC 40 ESG and Next 20 Paris Stock indices.
The goal of Atos is to help shape the future of the information space. Its expertise and services support the development of knowledge, education and research in a multicultural approach and contribute to the development of scientific and technological excellence. Around the world, the Group enables its customers and employees and members of societies in general to live, work and develop sustainably in a safe and secure information space.
Constance Arnoux | [email protected] † +33 6 44 12 16 35